{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:30:31Z","timestamp":1793946631811,"version":"4.8.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.exer.2026.111251","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:06:21Z","timestamp":1790697981000},"page":"111251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diabetic retinal disease revisited: Integrating neurovascular unit dysfunction and hemodynamics in pathophysiology and treatment"],"prefix":"10.1016","volume":"273","author":[{"given":"Teruyo","family":"Kida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Flammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2026.111251_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2018.06.025","article-title":"Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats","volume":"176","author":"Alrashdi","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111251_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/db21-0737","article-title":"Differentiating microaneurysm pathophysiology in diabetic retinopathy through objective analysis of capillary nonperfusion, inflammation, and pericytes","volume":"71","author":"An","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111251_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2026.111251_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaophthalmol.2016.2741","article-title":"Elimination of topical antibiotics for intravitreous injections and the importance of using povidone-iodine: update from the diabetic retinopathy clinical research network","volume":"134","author":"Bhavsar","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2026.111251_bib5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111251_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11892-016-0816-5","article-title":"Targeting Tie2 for treatment of diabetic retinopathy and diabetic macular edema","volume":"16","author":"Campochiaro","year":"2016","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.exer.2026.111251_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114983","article-title":"Research progress on the role of PDGF\/PDGFR in type 2 diabetes","volume":"164","author":"Cao","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exer.2026.111251_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00592-017-0996-8","article-title":"Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy","volume":"54","author":"Carnevali","year":"2017","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.exer.2026.111251_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/db23-0584","article-title":"Mechanical regulation of retinal vascular inflammation and degeneration in diabetes","volume":"73","author":"Chandrakumar","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111251_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1900\/RDS.2013.10.121","article-title":"Dyslipidemia and diabetic retinopathy","volume":"10","author":"Chang","year":"2013","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.exer.2026.111251_bib11","article-title":"Neurovascular unit uncoupling in diabetic retinopathy: molecular mechanisms and stage-adapted therapeutic strategies","volume":"17","author":"Chen","year":"2026","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2026.111251_bib12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/labinvest.3780139","article-title":"Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells","volume":"80","author":"Chen","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.exer.2026.111251_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12944-024-02064-6","article-title":"Remnant cholesterol is correlated with retinal vascular morphology and diabetic retinopathy in type 2 diabetes mellitus: a cross-sectional study","volume":"23","author":"Chen","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.exer.2026.111251_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mvr.2017.05.010","article-title":"Homocysteine up-regulates endothelin type A receptor in vascular smooth muscle cells through Sirt1\/ERK1\/2 signaling pathway","volume":"114","author":"Chen","year":"2017","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.exer.2026.111251_bib15","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3390\/jcm13102778","article-title":"Beyond VEGF: angiopoietin-tie signaling pathway in diabetic retinopathy","volume":"13","author":"Chen-Li","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.exer.2026.111251_bib16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","article-title":"Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) report 22","volume":"114","author":"Chew","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib17","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-023-34673-z","article-title":"Efficacy and safety profile of intravitreal dexamethasone implant versus antivascular endothelial growth factor treatment in diabetic macular edema: a systematic review and meta-analysis","volume":"13","author":"Chi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2026.111251_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s13063-022-06527-y","article-title":"HORNBILL: a phase I\/IIa trial examining the safety, tolerability and early response of BI 764524 in patients with diabetic retinopathy and diabetic macular ischaemia-rationale, study design and protocol","volume":"23","author":"Chong","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.exer.2026.111251_bib19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCRESAHA.110.223552","article-title":"Epigenetics: mechanisms and implications for diabetic complications","volume":"107","author":"Cooper","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.exer.2026.111251_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41591-024-02802-4","article-title":"Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results","volume":"30","author":"Crespo-Garcia","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2026.111251_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13167-015-0027-1","article-title":"Patients with diabetic retinopathy have high retinal venous pressure","volume":"6","author":"Cybulska-Heinrich","year":"2015","journal-title":"EPMA J."},{"key":"10.1016\/j.exer.2026.111251_bib22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/biology14070736","article-title":"Pericytes as key players in retinal diseases: a comprehensive narrative review","volume":"14","author":"D'Esposito","year":"2025","journal-title":"Biology"},{"key":"10.1016\/j.exer.2026.111251_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/02713683.2025.2601181","article-title":"Independent conjunctival and retinal microcirculatory improvements following ocufolin(\u00ae) supplementation in mild diabetic retinopathy","volume":"51","author":"Dai","year":"2026","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2026.111251_bib24","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1097\/IAE.0000000000000882","article-title":"Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography","volume":"35","author":"de Carlo","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.exer.2026.111251_bib25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2026.111251_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.109135","article-title":"The use of fenofibrate in diabetic retinopathy: narrative review","volume":"39","author":"Dissanayake","year":"2025","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.exer.2026.111251_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/jdi.70209","article-title":"MiR-155-5p promotes endothelial-mesenchymal transition and oxidative stress in diabetic retinopathy","volume":"17","author":"Dou","year":"2026","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.exer.2026.111251_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.exer.2026.111251_bib29","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archopht.116.7.874","article-title":"Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial","volume":"116","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/0394632017748841","article-title":"Ultrastructure of neurovascular changes in human diabetic retinopathy","volume":"31","author":"Feh\u00e9r","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.exer.2026.111251_bib31","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI58832","article-title":"Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling","volume":"122","author":"Felcht","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.exer.2026.111251_bib32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1476-5381.1993.tb13657.x","article-title":"Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors","volume":"109","author":"Filep","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2026.111251_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13167-015-0043-1","article-title":"Retinal venous pressure: the role of endothelin","volume":"6","author":"Flammer","year":"2015","journal-title":"EPMA J."},{"key":"10.1016\/j.exer.2026.111251_bib34","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0161-6420(03)00568-2","article-title":"Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema","volume":"110","author":"Funatsu","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111251_bib35","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ophtha.2004.11.045","article-title":"Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema","volume":"112","author":"Funatsu","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111251_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00417-016-3548-y","article-title":"The neurovascular unit and the pathophysiologic basis of diabetic retinopathy","volume":"255","author":"Gardner","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.visres.2017.04.010","article-title":"The role of dyslipidemia in diabetic retinopathy","volume":"139","author":"Hammer","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2026.111251_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00125-017-4435-8","article-title":"Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond","volume":"61","author":"Hammes","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2026.111251_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/db10-0454","article-title":"Diabetic retinopathy: targeting vasoregression","volume":"60","author":"Hammes","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111251_bib39","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2337\/diabetes.51.10.3107","article-title":"Pericytes and the pathogenesis of diabetic retinopathy","volume":"51","author":"Hammes","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111251_bib41","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2337\/dc14-2898","article-title":"Glycemic variability and diabetes complications: does it matter? Of course it does","volume":"38","author":"Hirsch","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2026.111251_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/IAE.0000000000002805","article-title":"Intraoperative three-dimensional fluorescein angiography-guided pars plana vitrectomy for the treatment of proliferative diabetic retinopathy: the maximized utility of the digital assisted vitrectomy","volume":"43","author":"Imai","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.exer.2026.111251_bib43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2026.111251_bib44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.aopr.2025.03.001","article-title":"The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration","volume":"5","author":"Josifova","year":"2025","journal-title":"Adv. Ophthalmol. Pract. Res."},{"key":"10.1016\/j.exer.2026.111251_bib45","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db11-0082","article-title":"Diabetes complications: the microRNA perspective","volume":"60","author":"Kantharidis","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111251_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110236","article-title":"miRNAs, piRNAs, and lncRNAs: a triad of non-coding RNAs regulating the neurovascular unit in diabetic retinopathy and their therapeutic potentials","volume":"251","author":"Karpagavalli","year":"2025","journal-title":"Exp. Eye Res."},{"issue":"26","key":"10.1016\/j.exer.2026.111251_bib47","article-title":"Retinal pericytes and their role in proliferative retinopathies","volume":"S0002\u20139440","author":"Kaushik","year":"2026","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2026.111251_bib48","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.19082\/5031","article-title":"Role of angiopoietins and Tie-2 in diabetic retinopathy","volume":"9","author":"Khalaf","year":"2017","journal-title":"Electron. Physician"},{"key":"10.1016\/j.exer.2026.111251_bib49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.oret.2017.08.020","article-title":"Intraoperative OCT-assisted surgery for proliferative diabetic retinopathy in the DISCOVER Study","volume":"2","author":"Khan","year":"2018","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.exer.2026.111251_bib54","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00417-020-05068-x","article-title":"Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion-related macular edema","volume":"259","author":"Kida","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.exer.2018.07.016","article-title":"Vasoactivity of retinal veins: a potential involvement of endothelin-1 (ET-1) in the pathogenesis of retinal vein occlusion (RVO)","volume":"176","author":"Kida","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111251_bib50","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1167\/iovs.15-17534","article-title":"NADPH oxidase-mediated ROS Production Determines insulin's action on the retinal microvasculature","volume":"56","author":"Kida","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111251_bib52","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00417-019-04324-z","article-title":"Protein kinase C-mediated insulin receptor phosphorylation in diabetic rat retina","volume":"257","author":"Kida","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib53","article-title":"Hyperglycemia-induced VEGF and ROS production in retinal cells is inhibited by the mTOR inhibitor, rapamycin","volume":"1885","author":"Kida","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2026.111251_bib55","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"102","author":"Klein","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib56","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","article-title":"Protein kinase C activation and the development of diabetic complications","volume":"47","author":"Koya","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111251_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/cells15040357","article-title":"Regulation of mitochondrial biogenesis in diabetic retinopathy","volume":"15","author":"Kumar","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.exer.2026.111251_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12035-025-05546-5","article-title":"Crosstalk between neuronal and glial cells in diabetic retinopathy: mechanisms and implications for neurodegeneration","volume":"63","author":"Kumari","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.exer.2026.111251_bib59","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4093\/dmj.2018.0182","article-title":"Pathophysiology of diabetic retinopathy: the old and the new","volume":"42","author":"Kusuhara","year":"2018","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.exer.2026.111251_bib60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1570161033476600","article-title":"Role of endothelin in diabetic retinopathy","volume":"1","author":"Lam","year":"2003","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.exer.2026.111251_bib61","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/24741264211028441","article-title":"Intravitreal injection therapy: current techniques and supplemental services","volume":"5","author":"Lam","year":"2021","journal-title":"J. Vitreoretin. Dis."},{"key":"10.1016\/j.exer.2026.111251_bib62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13098-018-0362-1","article-title":"Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis","volume":"10","author":"Lei","year":"2018","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.exer.2026.111251_bib63","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1007\/s00125-011-2081-0","article-title":"Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal M\u00fcller cells","volume":"54","author":"Lin","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2026.111251_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1108394","article-title":"Advances in targeted retinal photocoagulation in the treatment of diabetic retinopathy","volume":"14","author":"Lin","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2026.111251_bib65","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2147\/OPTH.S358753","article-title":"Improved retinal microcirculation in mild diabetic retinopathy patients carrying MTHFR polymorphisms who received the medical food","volume":"16","author":"Liu","year":"2022","journal-title":"Ocufolin\u00ae. Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/antiox13030254","article-title":"Diabetic retinopathy and regulation of mitochondrial glutathione-glutathione peroxidase axis in hyperhomocysteinemia","volume":"13","author":"Malaviya","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.exer.2026.111251_bib67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41419-020-02990-0","article-title":"Endothelin 1-induced retinal ganglion cell death is largely mediated by JUN activation","volume":"11","author":"Marola","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exer.2026.111251_bib68","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.survophthal.2021.08.011","article-title":"Clinical electroretinography in diabetic retinopathy: a review","volume":"67","author":"McAnany","year":"2022","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib69","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jdiacomp.2013.09.010","article-title":"Vitreous biomarkers in diabetic retinopathy: a systematic review and meta-analysis","volume":"28","author":"McAuley","year":"2014","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.exer.2026.111251_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70243","article-title":"Targeted micronutrient supplementation in diabetic retinopathy with MTHFR polymorphisms: biomarker shifts and clinical uncertainty","volume":"44","author":"Msa","year":"2026","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.exer.2026.111251_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2026.111118","article-title":"Plasma homocysteine and Endothelin-1 dysregulation: insights into retinal endothelial dysfunction","volume":"270","author":"Msa","year":"2026","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111251_bib72","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s001250050747","article-title":"The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas","volume":"40","author":"Murata","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2026.111251_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.exer.2026.111251_bib75","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000048323","article-title":"Gene expression of neurotrophins and their high-affinity Trk receptors in cultured human M\u00fcller cells","volume":"34","author":"Oku","year":"2002","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2026.111251_bib74","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00006982-200112000-00013","article-title":"Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy","volume":"21","author":"Oku","year":"2001","journal-title":"Retina"},{"key":"10.1016\/j.exer.2026.111251_bib76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/ijerph19010439","article-title":"Neurovascular impairment and therapeutic strategies in diabetic retinopathy","volume":"19","author":"Oshitari","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.exer.2026.111251_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110243","article-title":"Pharmacological depletion of pericytes induces diabetic retinopathy-like abnormal blood vessels in neonatal rat retina","volume":"251","author":"Otsuka","year":"2025","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2026.111251_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15296","article-title":"Plastic roles of pericytes in the blood-retinal barrier","volume":"8","author":"Park","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2026.111251_bib78","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2337\/db13-1942","article-title":"Angiopoietin 2 induces pericyte apoptosis via \u03b13\u03b21 integrin signaling in diabetic retinopathy","volume":"63","author":"Park","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.111251_bib80","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/ijms19040942","article-title":"Role of inflammation in diabetic retinopathy","volume":"19","author":"R\u00fcbsam","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2026.111251_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.exer.2026.111251_bib82","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1469-7793.1999.00637.x","article-title":"Physiology of rat retinal pericytes: modulation of ion channel activity by serum-derived molecules","volume":"3","author":"Sakagami","year":"1999","journal-title":"J. Physiol. 521 Pt"},{"key":"10.1016\/j.exer.2026.111251_bib83","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00417-023-06121-1","article-title":"Changes in the preoperative ocular surface flora with an increase in patient age: a surveillance analysis of bacterial diversity and resistance to fluoroquinolone","volume":"261","author":"Sakisaka","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib85","first-page":"326","article-title":"A pilot study to assess the effect of a three-month vitamin supplementation containing L-methylfolate on systemic homocysteine plasma concentrations and retinal blood flow in patients with diabetes","volume":"26","author":"Schmidl","year":"2020","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2026.111251_bib84","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000458539","article-title":"Guidelines for the management of diabetic macular edema by the European Society of retina specialists (EURETINA)","volume":"237","author":"Schmidt-Erfurth","year":"2017","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.exer.2026.111251_bib86","first-page":"1101","article-title":"Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin","volume":"231","author":"Shaw","year":"2006","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.exer.2026.111251_bib87","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.survophthal.2024.07.001","article-title":"Diabetic retinopathy: new concepts of screening, monitoring, and interventions","volume":"69","author":"Sinclair","year":"2024","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib88","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41433-025-03835-w","article-title":"New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A\/Nrp1 pathway","volume":"39","author":"Sivaprasad","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.exer.2026.111251_bib89","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00125-009-1622-2","article-title":"Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study)","volume":"53","author":"Sone","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2026.111251_bib90","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/pharmaceutics17070858","article-title":"Efficacy of faricimab in the treatment of diabetic macular edema and faricimab-related changes in OCT and OCT angiography","volume":"17","author":"\u015apiewak","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exer.2026.111251_bib91","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jnr.20383","article-title":"Endothelin-1 modulates anterograde fast axonal transport in the central nervous system","volume":"79","author":"Stokely","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2026.111251_bib92","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0004","article-title":"Peripheral blood HIF-1\u03b1 levels: a study on their predictive ability for early-stage diabetic retinopathy","volume":"14","author":"Su","year":"2025","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.exer.2026.111251_bib93","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1053-2498(01)00346-1","article-title":"Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion","volume":"21","author":"Taghavi","year":"2002","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.exer.2026.111251_bib95","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.exer.2026.111251_bib94","first-page":"107","article-title":"Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much? Redox","volume":"19","author":"Tan","year":"2014","journal-title":"Rep"},{"key":"10.1016\/j.exer.2026.111251_bib96","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.visres.2017.06.015","article-title":"Novel therapeutic targets in diabetic macular edema: beyond VEGF","volume":"139","author":"Urias","year":"2017","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2026.111251_bib98","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/iovs.67.1.24","article-title":"Silencing of lncRNA HOTAIR using eyedrops as a potential treatment for diabetes-associated retinal dysregulation and dysfunction","volume":"67","author":"Wang","year":"2026","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111251_bib97","doi-asserted-by":"crossref","DOI":"10.1177\/11772719251378813","article-title":"Blood based vascular marker responses to ocufolin(\u00ae) in diabetic retinopathy patients carrying MTHFR polymorphisms","volume":"20","author":"Wang","year":"2025","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.exer.2026.111251_bib99","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial","volume":"123","author":"Wells","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2026.111251_bib100","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Gross","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.exer.2026.111251_bib102","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010627","article-title":"Pulse pressure is a stronger predictor than systolic blood pressure for severe eye diseases in diabetes mellitus","volume":"8","author":"Yamamoto","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.exer.2026.111251_bib101","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fendo.2013.00105","article-title":"RAGE-mediated inflammation, type 2 diabetes, and diabetic vascular complication","volume":"4","author":"Yamamoto","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2026.111251_bib103","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.exer.2026.111251_bib104","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00417-020-04936-w","article-title":"Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema","volume":"259","author":"Yoshida","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111251_bib105","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1167\/iovs.15-18358","article-title":"Local modulation of retinal vein tone","volume":"57","author":"Yu","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111251_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41433-023-02396-0","article-title":"Infographic: panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy (PDR): drcr.net protocol S","volume":"38","author":"Yusuf","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.exer.2026.111251_bib107","first-page":"1015","article-title":"Effect of Ox-LDL on endothelium-dependent response in pig ciliary artery: prevention by an ET(A) antagonist","volume":"40","author":"Zhu","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111251_bib108","article-title":"Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang\/Tie, and inflammatory pathways","volume":"16","author":"Zong","year":"2025","journal-title":"Front. Endocrinol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526004070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526004070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:50:49Z","timestamp":1793944249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526004070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":108,"alternative-id":["S0014483526004070"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111251","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic retinal disease revisited: Integrating neurovascular unit dysfunction and hemodynamics in pathophysiology and treatment","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111251"}}